Sustained non-shockable rhythm | Sustained shockable rhythm | Converted from non-shockable to shockable rhythm | p | χ² | |
---|---|---|---|---|---|
Cases | 1709 | 595 | 487 | - | - |
Median age (IQR) | 69.0 (58.0–78.0) | 63.0 (55.0–73.0) | 67.0 (57.0–77.0) | < 0.001 | 38.7 |
Men (%) | 1134 (66.43) | 472 (79.33) | 361 (74.13) | < 0.001 | 39.0 |
CA characteristics, and ALS | |||||
Medical cause (vs. non-medical) | 1554 (90.93) | 574 (96.47) | 464 (95.28) | < 0.001 | 25.6 |
Public CA (%) | 393 (27.77) | 247 (49.30) | 143 (32.35)) | < 0.001 | 83.5 |
Witnessed (%) | 1164 (68.11) | 500 (84.03) | 370 (75.98) | < 0.001 | 59.5 |
Bystander CPR (%) | 459 (26.86) | 257 (43.19) | 143 (29.36) | < 0.001 | 65.5 |
CA recognized* (%) | 606 (35.46) | 296 (49.75) | 190 (39.01) | < 0.001 | 32.1 |
DA-CPR* (%) | 448 (26.21) | 250 (52.02) | 155 (31.83) | < 0.001 | 43.0 |
ET (%) | 189 (11.06) | 50 (8.40) | 58 (11.91) | 0.118 | 4.27 |
i-GEL (%) | 1465 (85.72) | 482 (81.01) | 419 (83.04) | 0.016 | 8.33 |
Adrenaline total dose, mg | 5.0 (2.0) | 5.0 (4.0) | 6.0 (4.0) | < 0.001 | 59.8 |
Mechanical compression machine (%) | 502 (29.37) | 167 (28.07) | 203 (41.68) | < 0.001 | 30.3 |
Comorbidities (%) | |||||
CVD* | 737 (43.12) | 245 (41.18) | 228 (46.82) | 0.168 | 3.56 |
Diabetes mellitus | 208 (12.17) | 38 (6.39) | 59 (12.11) | < 0.001 | 16.0 |
Malignancy | 110 (6.44) | 19 (3.19) | 21 (4.31) | 0.005 | 10.4 |
Renal disease | 42 (2.46) | 7 (1.18) | 8 (1.64) | 0.129 | 4.09 |
Pulmonary | 124 (7.26) | 19 (3.19) | 18 (3.70) | < 0.001 | 18.1 |
Psychiatric disease | 116 (6.79) | 17 (2.86) | 12 (2.46) | < 0.001 | 22.8 |
Neurological | 114 (6.67) | 16 (2.69) | 25 (5.13) | 0.001 | 13.5 |
Median time intervals, min (IQR) | |||||
Bystander reaction interval (n = 1222) | 2.0 (1.0–4.0) | 2.0 (1.0–3.0) | 2.0 (1.0–4.0) | 0.005 | 10.6 |
EMS Response interval (n = 2101) | 9.0 (7.0–13.0) | 8.0 (6.0-10.3) | 9.0 (7.0–12.0) | < 0.001 | 49.6 |
ROSC at hospital admission (%) | 257 (15.04) | 298 (50.01) | 149 (30.60) | < 0.001 | 296.0 |